Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Heike Richly

Funktionen

  • Mitglied/er, Innere Klinik (Tumorforschung)

Aktuelle Veranstaltungen

Keine aktuellen Veranstaltungen.

Vergangene Veranstaltungen (max. 10)

Keine vergangenen Veranstaltungen.

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Tomsitz, Dirk; Ruf, Theresa; Heppt, Markus; Staeger, Ramon; Ramelyte, Egle; Dummer, Reinhard; Garzarolli, Marlene; Meier, Friedegund; Meier, Eileen; Richly, Heike; Gromke, Tanja; Siveke, Jens T.; Franklin, Cindy; Klespe, Kai-Christian; Mauch, Cornelia; Kilian, Teresa; Seegräber, Marlene; Schilling, Bastian; French, Lars E.; Berking, Carola; Heinzerling, Lucie
    Tebentafusp in Patients with Metastatic Uveal Melanoma : A Real-Life Retrospective Multicenter Study
    In: Cancers Jg. 15 (2023) Nr. 13, 3430
    Online Volltext: dx.doi.org/ (Open Access)
  • Zensen, Sebastian; Opitz, Marcel K.; Ludwig, Johannes M.; Haubold, Johannes; Richly, Heike; Siveke, Jens; Theysohn, Jens; Forsting, Michael; Bos, Denise; Schaarschmidt, Benedikt M.
    Radiation Dose Aspects of Hepatic Artery Infusion Chemotherapy in Uveal Melanoma Patients with Liver Metastases
    In: Cardiovascular and Interventional Radiology Jg. 45 (2022) Nr. 6, S. 841 - 845
    Online Volltext: dx.doi.org/ (Open Access)
  • Le Guin, Claudia H. D.; Bornfeld, Norbert; Bechrakis, Nikolaos E.; Jabbarli, Leyla; Richly, Heike; Lohmann, Dietmar; Zeschnigk, Michael
    Early detection of metastatic uveal melanoma by the analysis of tumor-specific mutations in cell-free plasma DNA
    In: Cancer Medicine (2021) in press
    Online Volltext: dx.doi.org/ (Open Access)
  • Ludwig, Johannes; Haubold, Johannes; Heusner, Till Alexander; Bauer, Sebastian; Siveke, Jens; Richly, Heike; Wetter, Axel; Umutlu, Lale; Theysohn, Jens
    Laktatdehydrogenase vor transarterieller hepatischer Chemoperfusion prognostiziert das Überleben und den Tumorprogress bei Patienten mit Lebermetastasen bei Aderhautmelanom
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren Jg. 193 (2021) Nr. 06, S. 683 - 691
    Online Volltext: dx.doi.org/ (Open Access)
  • Ludwig, Johannes M.; Haubold, Johannes; Bauer, Sebastian; Richly, Heike; Siveke, Jens; Wimmer, Julia; Umutlu, Lale; Schaarschmidt, Benedikt M.; Theysohn, Jens
    Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion
    In: Radiology and Oncology Jg. 55 (2021) Nr. 3, S. 347 - 353
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Welt, Anja; Bogner, Simon; Arendt, Marina; Kossow, Josef; Huffziger, Antonia; Pohlkamp, Christian; Steiniger, Heike; Becker, Ute; Alashkar, Ferras; Kohl, Marzena; Wiesweg, Marcel; Richly, Heike; Hense, Jörg; Scheulen, Max Ernst; Schuler, Martin; Seeber, Siegfried; Tewes, Mitra
    Improved survival in metastatic breast cancer : results from a 20-year study involving 1033 women treated at a single comprehensive cancer center
    In: Journal of Cancer Research and Clinical Oncology (2020)
    Online Volltext: dx.doi.org/ (Open Access)
  • Schuler, Martin; Cho, Byoung Chul; Sayehli, Cyrus Michael; Navarro, Alejandro; Soo, Ross A.; Richly, Heike; Cassier, Philippe Alexandre; Tai, David; Penel, Nicolas; Nogova, Lucia; Park, Se Hoon; Schostak, Martin; Gajate, Pablo; Cathomas, Richard; Rajagopalan, Prabhu; Grevel, Joachim; Bender, Sebastian; Boix, Oliver; Nogai, Hendrik; Ocker, Matthias; Ellinghaus, Peter; Joerger, Markus
    Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression : a phase 1 dose-escalation and dose-expansion study
    In: The Lancet Oncology Jg. 20 (2019) Nr. 10, S. 1454 - 1466
    Online Volltext: dx.doi.org/
  • Sahin, Ugur; Schuler, Martin; Richly, Heike; Bauer, Stefan; Krilova, Anna; Dechow, Tobias; Jerling, Markus; Utsch, Magdalena; Rohde, Christoph; Dhaene, Karl; Huber, Christoph; Türeci, Özlem
    A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
    In: European Journal of Cancer (EJC) Jg. 100 (2018) S. 17 - 26
    Online Volltext: dx.doi.org/ (Open Access)
  • Glossmann, Jan‑Peter; Skoetz, Nicole; Starbatty, Barbara; Bischoff, Martina; Leyvraz, Serge; Westekemper, Henrike; Materna, Verena; Troost, Esther; Noak, Karina; Benito Rabenort, Michael; Palm, Stefan; Kemink, Timm; Degener, Kristina; Reimer, Carola; Schafhausen, Philippe; Dietrich, Mareike; Hale, Katrin; Scheid, Christof; Schneider, Victoria; Pretzell, Elke Ina; Dorn, Julia; Böck, Stefan; Kraus-Pfeiffer, Gabriele; Seckinger, Andrea; Sommer, Rebekka; Schauer, Ute; Krein, Axel; Meier, Friedegund; Sommer, Falk; Kreis, Stefan; Richly, Heike; Bauer, Sebastian; Griewank, Klaus; Hrgovic, Igor; Meissner, Markus; Wolff, Robert; Auw-Hädrich, Claudia; Reinhard, Thomas; von Bubnoff, Dagmar; Fuisting, Bettina; Staub, Janina; Hassel, Jessica C.; Marnitz-Schulze, Karolina Simone; Schlaak, Max; Laspas, Panagiotis; Loquai, Carmen; Siedlecki, Jakob; Süsskind, Daniela; Paulsen, Frank; Eigentler, Thomas; Treiber, Nikolai; Ach, Thomas; Gesierich, Anja; Kampik, Daniel; Heindl, Ludwig M.
    Konjunktivales Melanom : Standardisiertes Vorgehen in Diagnostik, Therapie und Nachsorge
    In: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft Jg. 115 (2018) Nr. 6, S. 489 - 498
    Online Volltext: dx.doi.org/
  • Joerger, M.; Soo, R. A.; Cho, B. C.; Navarro, A.; Sayehli, C. M.; Richly, Heike; Tai, D.; Kim, D. W.; Wolf, J.; Cassier, P.; Bender, S.; Ellinghaus, P.; Ince, S.; Rajagopalan, P.; Ocker, M.; Schuler, Martin
    A novel mRNA-based patient selection strategy identifies fibroblast growth factor receptor (FGFR) inhibitor-sensitive tumors : Results from rogaratinib Phase-1 study
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Scheulen, Max Ernst; Kaempgen, Eckhart; Keilholz, Ulrich; Heinzerling, Lucie; Ochsenreither, Sebastian; Abendroth, Annalena; Huger, Ralf A.; Grubert, Matthias; Wetter, Axel; Guberina, Nika; Bauer, Sebastian; Schuler, Gerold; Bornfeld, Norbert; Schuler, Martin; Richly, Heike
    STREAM : A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (5) treatment of chemonaive patients (pts) with metastatic uveal melanoma (MUM)
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 15, S. 9511
    Online Volltext: dx.doi.org/
  • Mross, Klaus; Richly, Heike; Frost, Annette; Scharr, Dirk; Nokay, Bahar; Graeser, Ralph; Lee, Chooi; Hilbert, James; Goeldner, Rainer-George; Fietz, Oliver; Scheulen, Max Ernst
    A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors
    In: Cancer Chemotherapy and Pharmacology Jg. 78 (2016) Nr. 2, S. 405 - 417
    Online Volltext: dx.doi.org/ (Open Access)
  • Joerger, M.; Soo, R.; Cho, B.C.; Mendivil, A. Navarro; Sayehli, C.; Richly, Heike; Tai, D.; Kim, D.-W.; Wolf, J.; Cassier, P.; Ellinghaus, P.; Hildebrandt, S.; Behre, S.; Helmbrecht, C.; Kerpen, S.; Zielinski, D.; Ince, S.; Rajagopalan, P.; Ocker, M.; Schuler, Martin
    developmental therapeuticsPhase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, 360O_PR
    Online Volltext: dx.doi.org/
  • Bergmann, Lothar; Maute, Luise; Heil, G.; Rüssel, Jörn; Weidmann, Eckhart; Köberle, Dieter; Fuxius, Stefan; Weigang-Köhler, Karin; Aulitzky, Walter E.; Wörmann, B.; Hartung, G.; Moritz, B.; Edler, Lutz A.; Burkholder, Iris; Scheulen, Max Ernst; Richly, Heike
    A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer : a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
    In: European journal of cancer Jg. 51 (2015) Nr. 1, S. 27 - 36
    Online Volltext: dx.doi.org/
  • Schelhorn, Juliane; Richly, Heike; Ruhlmann, Marcus; Lauenstein, Thomas; Theysohn, Jens
    A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma
    In: Acta Radiologica Open Jg. 4 (2015) Nr. 4,
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Richly, Heike; Kim, Tae Min; Schuler, Martin; Kim, Dong-Wan; Harrison, Simon J.; Shaw, Alice T.; Boral, Anthony L.; Yovine, Alejandro; Solomon, Benjamin
    Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma
    In: Blood Jg. 126 (2015) Nr. 10, S. 1257 - 1258
    Online Volltext: dx.doi.org/
  • Mross, Klaus B.; Scharr, Dirk; Richly, Heike; Bauer, Sebastian; Krauss, Babett; Krauss, Rolf; Hauns, Bernhard; Prenzel, Tanja; Kohlhof, Hella; Baumgartner, Roland; Scheulen, Max Ernst
    Overcoming the proliferation rate paradox : Clinical evaluation of a continuous dosing scheme of the novel oral Eg5 inhibitor 4SC-205
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 2528
    Online Volltext: dx.doi.org/ Online Volltext
  • Weihrauch, Martin R.; Richly, Heike; Bergwelt-Baildon, Michael S. von; Becker, Hans J.; Schmidt, Manuel; Hacker, Ulrich T.; Shimabukuro-Vornhagen, Alexander; Holtick, Udo; Nokay, Bahar; Schroff, Matthias; Wittig, Burghardt; Scheulen, Max Ernst
    Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours
    In: European journal of cancer Jg. 51 (2015) Nr. 2, S. 146 - 156
    Online Volltext: dx.doi.org/
  • Mross, K. B.; Scharr, D.; Richly, Heike; Frost, A.; Bauer, Sebastian; Krause, B.; Krause, R.; Mals, A.; Hauns, B.; Hentsch, B.; Baumgartner, R.; Scheulen, Max Ernst
    First-in-human study of 4SC-205 (AEGIS), a novel oral inhibitor of Eg5 kinesin spindle protein
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 2564
    Online Volltext: dx.doi.org/
  • Ahnert, J. R.; Schuler, Martin; Machiels, JPH; Hess, D.; Paz-Ares, L.; Awada, A.; von Moos, R.; Steeghs, N.; Zambrano, C. C.; De Mesmaeker, P.; Richly, Heike; Herremans, C.; Joerger, M.; Jaime, J. C.; Alsina, M.; Baffert, F.; Demanse, D.; Duval, V.; Morozov, A.; Dirix, L.
    Phase lb study of BEZ235 plus either paclitaxel (PTX) in advanced solid tumors (aST) or PTX plus trastuzumab (TZ) in HER2+ breast cancer (BC)
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 621
    Online Volltext: dx.doi.org/
  • Zambrano, C. C.; Schuler, Martin; Machiels, JPH; Hess, D.; Paz-Ares, L.; Awada, A.; von Moos, R.; Steeghs, N.; Ahnert, J. R.; De Mesmaeker, P.; Richly, Heike; Herremans, C.; Joerger, M.; Jaime, J. C.; Alsina, M.; Baffert, F.; Demanse, D.; Duval, V.; Morozov, A.; Dirix, L.
    Phase lb study of buparlisib (BKM120) plus either paclitaxel (PTX) in advanced solid tumors (aST) or PTX plus trastuzumab (TZ) in HER2+ breast cancer (BC)
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 627
    Online Volltext: dx.doi.org/
  • Plummer, Ruth; Madi, Ayman; Jeffels, Melinda; Richly, Heike; Nokay, Bahar; Rubin, Stephen; Ball, Howard A.; Weller, Steve; Botbyl, Jeffrey; Gibson, Diana M.; Scheulen, Max Ernst
    A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    In: Cancer Chemotherapy and Pharmacology: CPP Jg. 71 (2013) Nr. 1, S. 93 - 101
    Online Volltext: dx.doi.org/
  • Mayer, Erica L.; Scheulen, Max Ernst; Beckman, J.; Richly, Heike; Duarte, A.; Cotreau, M.M.; Strahs, A.L.; Agarwal, S.; Steelman, L.; Winer, E.P.; Dickler, M.N.
    A Phase i dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer
    In: Breast Cancer Research and Treatment Jg. 140 (2013) Nr. 2, S. 331 - 339
    Online Volltext: dx.doi.org/
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin
    Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
    In: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. 15, S. 3076 - 3082
    Online Volltext: dx.doi.org/
  • Mross, Klaus; Richly, Heike; Fischer, Richard; Scharr, Dirk; Büchert, Martin; Stern, Angelika; Gille, Hendrik; Audoly, Laurent P.; Scheulen, Max Ernst
    First-in-human phase i study of PRS-050 (Angiocal), an anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors
    In: PLoS ONE Jg. 8 (2013) Nr. 12, S. e83232
    Online Volltext: dx.doi.org/ (Open Access)
  • Welt, Anja; Tewes, Mitra; Aktas, Bahriye; Hoffmann, Oliver; Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Richly, Heike; Hense, Jörg; Palmer, Michael R.; Lee, Benjamin H.; Wendling, Johanna; Kossow, Josef; Scheulen, Max Ernst; Lehnerdt, Cathrin; Kohl, Marzena; Derks, Cordula; Skottky, Silke; Haus, Ulrike; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Kasper, Stefan
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Breast Cancer Research and Treatment Jg. 142 (2013) Nr. 1, S. 81 - 88
    Online Volltext: dx.doi.org/
  • Richly, Heike; Maute, L.; Heil, G.; Russel, J.; Jager, E.; Koeberle, D.; Fuxius, S.; Weigang-Koehler, K.; Aulitzky, W.; Woehrmann, B.; Hartung, G. G.; Moritz, B.; Burkholder, I.; Scheulen, Max Ernst; Bergmann, L.
    Prospective randomized phase II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer : A study of the CESAR Central European Society for Anticancer Drug Research-EWIV
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. 4035
    Online Volltext: dx.doi.org/
  • Scheulen, Max Ernst; Richly, Heike; Kalkavan, H.; Hoffmann, Andreas-Claudius; Virchow, I.; Hilger, Ralf A.; Koeppen, Susanne; Sure, Ulrich; Schuler, Martin; Hense, Jörg
    An investigator-initiated monocentric phase I dose escalation trial of temsirolimus and irinotecan (TEMIR) in patients with relapsing glioblastoma multiforme (reGBM)
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15, S. 2086
  • Strumberg, Dirk; Scheulen, Max Ernst; Schultheis, B.; Richly, Heike; Frost, A.; Büchert, M.; Christensen, O.; Jeffers, M.; Heinig, R.; Boix, O.; Mross, K.
    Regorafenib (BAY 73-4506) in advanced colorectal cancer : a phase I study
    In: British Journal of Cancer (BJC) Jg. 106 (2012) Nr. 11, S. 1722 - 1727
    Online Volltext: dx.doi.org/ (Open Access)
  • Hilger, Ralf A.; Wegener, T.; Richly, Heike; Lutscher, N.; Ludwig, G.; Mross, K.; Scheulen, Max Ernst
    A clinical phase I study evaluating tolerability and pharmacokinetics (PK) of TriN 2755 in patients (pts) with advanced solid tumors : A study in cooperation with the Central European Society for Anticancer Drug Research (CESAR-EWIV)
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 109 - 110
  • Mayer, E. L.; Scheulen, Max Ernst; Beckman, J.; Richly, Heike; Poli, A.; Bhargava, P.; Duarte, A.; Cotreau, M. M.; Strahs, A. L.; Dickler, M. N.
    Combination of tivozanib (AV-951) with weekly paclitaxel for metastatic breast cancer : Results of a phase I study
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 1092
    Online Volltext: dx.doi.org/
  • Scheulen, Max Ernst; Nokay, B.; Richly, Heike; Hoffmann, Andreas-Claudius; Kalkmann, J.; Stattaus, Jörg; Bornfeld, Norbert; Schuler, Martin; Hense, Jörg
    Register trial of sorafenib (S) for patients (pts) with metastatic uveal melanoma (metUvMel)
    In: European Journal of Cancer (EJC) Jg. 47 (2011) Nr. Suppl. 4, S. S30
    Online Volltext: dx.doi.org/
  • Schmidt, M.; Holtick, U.; Nokay, B.; Richly, Heike; Tschaika, M.; Wittig, B.; von Bergwelt-Baildon, M.S.; Scheulen, Max Ernst; Weihrauch, M.R.; Hacker, U.
    46 Immunotherapy with the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumors - clinical efficacy and immunological results of a phase I study
    In: European Journal of Cancer / EJC Supplements Jg. 8 (2010) Nr. 7, S. 23 - 24
    Online Volltext: dx.doi.org/ (Open Access)
  • Nokay, B.; Richly, Heike; Hacker, U.; Wittig, B.; Weihrauch, M.R.; Schmidt, M.; Shimabukuro-Vornhagen, A.; Scheulen, Max Ernst; von Bergwelt-Baildon, M.S.; Tschaika, M.
    47 Immunotherapy with the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumors - safety results of a clinical phase I study
    In: European Journal of Cancer / EJC Supplements Jg. 8 (2010) Nr. 7, S. 24
    Online Volltext: dx.doi.org/ (Open Access)
  • Lee, K.H.; Hilbert, Josef; Mross, K.; Fietz, O.; Scharr, D.; Scheulen, Max Ernst; Richly, Heike; Nokay, B.; Frost, A.; Saunders, O.
    496 A phase I dose-escalation study of BI 811283, an Aurora B inhibitor, administered day 1 and 15 every four weeks, in patients with advanced solid tumours
    In: European Journal of Cancer / EJC Supplements Jg. 8 (2010) Nr. 7, S. 158 - 159
    Online Volltext: dx.doi.org/ (Open Access)
  • Rubin, S.D.; Plummer, R.; Scheulen, Max Ernst; Nokay, B.; Madi, A.; Richly, Heike; Jeffels, M.; Gibson, D.; Weller, S.
    50 A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors
    In: European Journal of Cancer / EJC Supplements Jg. 8 (2010) Nr. 7, S. 25
    Online Volltext: dx.doi.org/ (Open Access)
  • Scheulen, Max Ernst; Mross, K. B.; Richly, Heike; Nokay, B.; Frost, A.; Scharr, D.; Lee, K.; Saunders, O.; Hilbert, Josef; Fietz, O.
    A phase I dose-escalation study of BI 811283, an Aurora B inhibitor, administered days 1 and 15, every four weeks in patients with advanced solid tumors
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. e13065
    Online Volltext: dx.doi.org/
  • Al-Adhami, M.; Beckman, J.; Dickler, M.; Scheulen, Max Ernst; Mayer, E. L.; Poli, A.; Bhargava, P.; Duarte, A.; Richly, Heike; Cotreau, M.
    Abstract P2-16-10: Combination of Tivozanib, an Oral Inhibitor of VEGFR, with Weekly Paclitaxel for Metastatic Breast Cancer : Preliminary Results of an Ongoing Phase 1 Study
    In: Cancer Research Jg. 70 (2010) Nr. 24, S. P2 - 16
    Online Volltext: dx.doi.org/

    • Abstracts

  • Melero, Ignacio; Calvo, Emiliano; Goebeler, Maria-Elisabeth; Garralda, Elena; Dummer, Reinhard; Rodríguez-Ruiz, María; Miguel, Maria de; Sayehli, Cyrus Michael; Casal, Guzman Alonso; Ramelyte, Egle; Schuler, Martin; Gromke, Tanja; Sanmamed, Miguel; Moreno, Irene; Bargou, Ralf; Lostes, Maria; Maul, Julia-Tatjana; Eggenschwiler, Corinne; Richly, Heike; Fettes, Petra; Klar, Kathrin; Schuberth-Wagner, Christine; Haake, Markus; Wischhusen, Jörg; Leo, Eugen;
    A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced stage solid tumors (Acronym: GDFATHER)
    SITC 36th Anniversary Annual Meeting (SITC 2021), 10-14 November 2021, Washington & virtually,
    In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. Suppl. 2, S. A536 - A536
    Online Volltext: dx.doi.org/ (Open Access)
  • Joerger, Markus; Cassier, Philippe Alexandre; Penel, Nicolas; Cathomas, Richard; Richly, Heike; Schostak, Martin; Janitzky, Andreas; Wermke, Martin; Nogova, Lucia; Tai, David Wai-Meng; Sayehli, Cyrus; Grüllich, Carsten; Grande, Enrique; Navarro, Alejandro; Park, Se Hoon; Nogai, Hendrik; Bender, Sebastian; Ellinghaus, Peter; Schuler, Martin
    Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 4513 - 4513
    Online Volltext: dx.doi.org/ (Open Access)
  • Schuler, Martin; Cassier, P.; Penel, N.; Cathomas, R.; Richly, Heike; Schostak, M.; Janitzky, A.; Wermke, M.; Nogova, L.; Tai, D.; Sayehli, C.; Grüllich, C.; Grande, E.; Navarro, A.; Park, S. H.; Nogai, H.; Bender, S.; Ellinghaus, P.; Joerger, M.;
    Rogaratinib in patients with advanced urothelial carcinomas selected for tumor FGFR mRNA expression and impact of mutations in the FGFR signaling pathway
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; Wien, 28. September - 2. Oktober 2018,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 321
    Online Volltext: dx.doi.org/ (Open Access)
  • Sayehli, Cyrus; Nogova, Lucia; Nogai, Hendrik; Park, Se Hoon; Richly, Heike; Cathomas, Richard; Wermke, Martin; Bender, Sebastian; Navarro, Alejandra; Schostak, Martin; Grande, Enrique; Cassier, Philippe; Janitzky, Andreas; Penel, Nicolas; Ellinghaus, Peter; Tai, David Wai-Meng; Gillessen, Silke; Grüllich, Carsten; Joerger, Markus; Schuler, Martin
    Rogaratinib treatment of patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression.
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 6 Suppl., S. 494
    Online Volltext: dx.doi.org/ (Open Access)
  • Schuler, Martin; Nogova, L.; Heidenreich, A.; Tai, D.; Cassier, P.; Richly, Heike; Cho, B. C.; Sayehli, C. M.; Navarro, A.; Bender, Stefan; Ocker, M.; Nogai, H.; Wagner, A.; Ince, S.; Ellinghaus, P.; Joerger, M.
    Anti-tumor activity of the pan-FGFR inhibitor rogaratinib in patients with advanced urothelial carcinomas selected based on tumor FGFR mRNA expression levels
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Welt, Anja; Kasper, Stefan; Tewes, Mitra; Aktas, B.; Hoffmann, Oliver; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Palmer, M. R.; Lee, B. H.; Wendling, J.; Kossow, J.; Scheulen, Max Ernst; Lehnerdt, C.; Kohl, M.; Derks, C.; Slottky, S.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19
    Online Volltext: dx.doi.org/ (Open Access)
  • Richly, Heike; Scheulen, Max Ernst; Wiesweg, Marcel; Abendroth, A.; Schuler, Martin; Bauer, Sebastian;
    Systemic treatment of metastatic uveal melanoma - a silver lining on the horizon?
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 118 - 119
    Online Volltext: dx.doi.org/
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derks, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin;
    WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3
    Online Volltext: dx.doi.org/
  • Tewes, Mitra; Kasper, Stefan; Aktas, B.; Hoffmann, A.; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Kern, P.; Scheulen, Max Ernst; Skottky, S.; Peters, M.; Schlegel, R.; Lee, B. H.; Palmer, M. R.; Monahan, J. E.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Welt, Anja;
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Oncology Research and Treatment Jg. 36 (2013) Nr. Suppl. 7, S. 157
    Online Volltext: dx.doi.org/
  • Hilger, Ralf A.; Wegener, Tobias; Richly, Heike; Ludwig, Georg; Mross, Klaus; Scheulen, Max Ernst
    A phase I dose-escalation study with pharmacokinetics (PK) of TriN 2755 in patients with advanced solid tumors : A study in cooperation with the Central European Society for Anticancer Drug Research (CESAR-EWIV)
    In: Cancer Research Jg. 71 (2011) Nr. 8, Suppl., S. 1293
    Online Volltext: dx.doi.org/
  • Mross, K. B.; Scheulen, Max Ernst; Frost, A.; Scharr, D.; Richly, Heike; Nokay, B.; Lee, K.; Hilbert, J.; Fleischer, F.; Fietz, O.
    A phase I dose-escalation study of BI 811283, an Aurora B inhibitor, administered every three weeks in patients with advanced solid tumors
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. 15 Suppl., S. 3011
  • Kalkmann, J.; Richly, Heike; Forsting, Michael; Scheulen, Max Ernst; Stattaus, Jörg;
    Detection of new hepatic metastases in computed tomography (CT) with hepatic metastatic choroidal melanoma in Antiangiogenic Therapy - Progress or Pseudoprogression?
    29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 2, S. 188
    Online Volltext: dx.doi.org/
  • Kalkmann, J.; Richly, Heike; Forsting, Michael; Scheulen, Max Ernst; Stattaus, Jörg;
    Evaluation of lesions density in computed tomography (CT) for assessment of tumor response in patients with hepatic metastatic choroidal melanoma under therapy with sorafenib
    29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,
    In: Oncology Research and Treatment Jg. 33 (2010) Nr. Suppl. 2, S. 182
    Online Volltext: dx.doi.org/
  • Hilger, Ralf A.; Köhler, Johannes; Kalkavan, H.; Richly, Heike; Hoffmann, Andreas-Claudius; Heinrichs, D.; Azaouagh, A.; Schuler, Martin; Trarbach, Tanja;
    Interpatient pharmacokinetic variability of 5-FU within metastatic and adjuvant colon cancer patients : First results from the West German Cancer Center
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 173
    Online Volltext: dx.doi.org/

    • Dissertation

  • Richly, Heike;
    Entwicklung eines Bestimmungsverfahrens für albumingebundenes Doxorubicin und pharmakokinetische Untersuchung in der Maus
    Duisburg-Essen (2004) 96 Bl. : Ill., graph. Darst.